Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102096742 | 10209674 | 2 | F | 20150619 | 20140602 | 20150630 | EXP | US-BIOGENIDEC-2014BI049382 | BIOGEN | 0.00 | F | Y | 0.00000 | 20150630 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102096742 | 10209674 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | /wk | |||||||
| 102096742 | 10209674 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | SOLUTION FOR INJECTION | /wk | ||||||
| 102096742 | 10209674 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 7 | UG | /wk | |||||||
| 102096742 | 10209674 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | D | 103628 | 30 | UG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102096742 | 10209674 | 1 | Multiple sclerosis |
| 102096742 | 10209674 | 2 | Multiple sclerosis |
| 102096742 | 10209674 | 3 | Multiple sclerosis |
| 102096742 | 10209674 | 4 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102096742 | 10209674 | HO |
| 102096742 | 10209674 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102096742 | 10209674 | Abasia | |
| 102096742 | 10209674 | Blindness | |
| 102096742 | 10209674 | Cardiac failure congestive | |
| 102096742 | 10209674 | Coordination abnormal | |
| 102096742 | 10209674 | Foot fracture | |
| 102096742 | 10209674 | General physical health deterioration | |
| 102096742 | 10209674 | General symptom | |
| 102096742 | 10209674 | Headache | |
| 102096742 | 10209674 | Loss of consciousness | |
| 102096742 | 10209674 | Mobility decreased | |
| 102096742 | 10209674 | Muscle atrophy | |
| 102096742 | 10209674 | Muscle disorder | |
| 102096742 | 10209674 | Muscle spasms | |
| 102096742 | 10209674 | Myoclonic epilepsy | |
| 102096742 | 10209674 | Osteoporosis | |
| 102096742 | 10209674 | Peripheral swelling | |
| 102096742 | 10209674 | Renal impairment | |
| 102096742 | 10209674 | Seizure | |
| 102096742 | 10209674 | Sensory disturbance | |
| 102096742 | 10209674 | Sleep apnoea syndrome | |
| 102096742 | 10209674 | Tremor | |
| 102096742 | 10209674 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102096742 | 10209674 | 2 | 20060311 | 20070318 | 0 | |
| 102096742 | 10209674 | 3 | 20140523 | 0 |